Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, Brazil

Robert J. Wozniak(Cornell University), Camila Sunaitis Donini(Universidade de São Paulo), Natália B. Cerqueira(Universidade de São Paulo), Carrie D. Johnston(Apple (Israel)), Maria C Dantas(Universidade de São Paulo), Vivian Iida Avelino‐Silva(University of California, San Francisco), Daniel A C Barros(Universidade de São Paulo), Esper G. Kallás(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Jez L. Marston(Cornell University), Douglas F. Nixon(Cornell University), Thiago Sabino(Universidade de São Paulo), Manya Magnus(Milken Institute), Bianca Mahafe(Universidade de São Paulo), Edmilson Alves de Medeiros(Universidade de São Paulo), Albert Roggenbuck(Universidade de São Paulo), Ana Carolina Soares de Oliveira(Universidade de São Paulo), Sebastian C Bidegain(Cornell University)
BMJ Open
November 1, 2020
10.1136/bmjopen-2020-040092
Cited by 15

Related Papers

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function
|The Journal of Experimental Medicine|2000|864
Understanding Structural Barriers to Accessing HIV Testing and Prevention Services Among Black Men Who Have Sex with Men (BMSM) in the United States
|AIDS and Behavior|2014|303
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
|Vaccine|2009|276
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
|The Lancet HIV|2019|206